Skip to main content
. 2024 Mar 4;42(2):154–159. doi: 10.3857/roj.2023.00682

Table 1.

Comparison of the studies on surface mould brachytherapy for eyelid carcinomas

Guix et al. [15] Montero et al. [16] Vavassori et al. [2] Jain et al. [17] Our study
Number of patients 16 2 7 1 1
Histology BCC 16 BCC 2 BCC 5, SC 2 SCC 1 SC 1
Total dose 60–66 Gy/33–36 fx 44–48 Gy/11–12 fx 30–48 Gy/10–17 fx 40 Gy/10 fx 52 Gy/13 fx
Median follow-up (mo) - 15 (4–36) 51 (16–90) 40 6
Local control (%) 100 100 100 100 100
Good cosmetic outcome (%) 100 - 100 100 100

BCC, basal cell carcinoma; SCC, squamous cell carcinoma; SC, sebaceous carcinoma.